Global Orphan Drugs Sales Market Report 2017

November 2017 | 114 pages | ID: GFD039D207BWEN
QYResearch

Abstracts

In this report, the global Orphan Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Orphan Drugs for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Orphan Drugs market competition by top manufacturers/players, with Orphan Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Alexion Pharmaceuticals, Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• AstraZeneca
• Eisai Co., Ltd.
• Daiichi Sankyo Company Limited
• Bayer AG
• GlaxoSmithKline
• Merck & Co., Inc.
• Johnson & Johnson
• Biogen, Inc.
• Shire
• Amgen, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Oncology
• Gastrointestinal
• Pulmonary
• Neurology
• Hematology
• Cardio-vascular
• Metabolic disorders
• Endocrinology
• Infectious diseases
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Orphan Drugs for each application, including

• Hospital Pharmacies
• Speciality Pharmacies
• Retail pharmacies
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Orphan Drugs Sales Market Report 2017

1 ORPHAN DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Orphan Drugs
1.2 Classification of Orphan Drugs by Product Category
  1.2.1 Global Orphan Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Orphan Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oncology
  1.2.4 Gastrointestinal
  1.2.5 Pulmonary
  1.2.6 Neurology
  1.2.7 Hematology
  1.2.8 Cardio-vascular
  1.2.9 Metabolic disorders
  1.2.10 Endocrinology
  1.2.11 Infectious diseases
  1.2.12 Others
1.3 Global Orphan Drugs Market by Application/End Users
  1.3.1 Global Orphan Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacies
  1.3.3 Speciality Pharmacies
  1.3.4 Retail pharmacies
  1.3.5 Others
1.4 Global Orphan Drugs Market by Region
  1.4.1 Global Orphan Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Orphan Drugs Status and Prospect (2012-2022)
  1.4.3 China Orphan Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Orphan Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Orphan Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Orphan Drugs Status and Prospect (2012-2022)
  1.4.7 India Orphan Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Orphan Drugs (2012-2022)
  1.5.1 Global Orphan Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Orphan Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL ORPHAN DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Orphan Drugs Market Competition by Players/Suppliers
  2.1.1 Global Orphan Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Orphan Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Orphan Drugs (Volume and Value) by Type
  2.2.1 Global Orphan Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Orphan Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Orphan Drugs (Volume and Value) by Region
  2.3.1 Global Orphan Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Orphan Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Orphan Drugs (Volume) by Application

3 UNITED STATES ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Orphan Drugs Sales and Value (2012-2017)
  3.1.1 United States Orphan Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Orphan Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Orphan Drugs Sales Price Trend (2012-2017)
3.2 United States Orphan Drugs Sales Volume and Market Share by Players
3.3 United States Orphan Drugs Sales Volume and Market Share by Type
3.4 United States Orphan Drugs Sales Volume and Market Share by Application

4 CHINA ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Orphan Drugs Sales and Value (2012-2017)
  4.1.1 China Orphan Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Orphan Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Orphan Drugs Sales Price Trend (2012-2017)
4.2 China Orphan Drugs Sales Volume and Market Share by Players
4.3 China Orphan Drugs Sales Volume and Market Share by Type
4.4 China Orphan Drugs Sales Volume and Market Share by Application

5 EUROPE ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Orphan Drugs Sales and Value (2012-2017)
  5.1.1 Europe Orphan Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Orphan Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Orphan Drugs Sales Price Trend (2012-2017)
5.2 Europe Orphan Drugs Sales Volume and Market Share by Players
5.3 Europe Orphan Drugs Sales Volume and Market Share by Type
5.4 Europe Orphan Drugs Sales Volume and Market Share by Application

6 JAPAN ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Orphan Drugs Sales and Value (2012-2017)
  6.1.1 Japan Orphan Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Orphan Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Orphan Drugs Sales Price Trend (2012-2017)
6.2 Japan Orphan Drugs Sales Volume and Market Share by Players
6.3 Japan Orphan Drugs Sales Volume and Market Share by Type
6.4 Japan Orphan Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Orphan Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Orphan Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Orphan Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Orphan Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Orphan Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Orphan Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Orphan Drugs Sales Volume and Market Share by Application

8 INDIA ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Orphan Drugs Sales and Value (2012-2017)
  8.1.1 India Orphan Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Orphan Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Orphan Drugs Sales Price Trend (2012-2017)
8.2 India Orphan Drugs Sales Volume and Market Share by Players
8.3 India Orphan Drugs Sales Volume and Market Share by Type
8.4 India Orphan Drugs Sales Volume and Market Share by Application

9 GLOBAL ORPHAN DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Novartis AG
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Orphan Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Novartis AG Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Bristol-Myers Squibb Company
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Orphan Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Bristol-Myers Squibb Company Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Celgene Corporation
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Orphan Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Celgene Corporation Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 F. Hoffmann-La Roche Ltd.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Orphan Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 F. Hoffmann-La Roche Ltd. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Pfizer, Inc.
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Orphan Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Pfizer, Inc. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Sanofi S.A.
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Orphan Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Sanofi S.A. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Alexion Pharmaceuticals, Inc.
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Orphan Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Alexion Pharmaceuticals, Inc. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Eli Lilly and Company
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Orphan Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Eli Lilly and Company Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Novo Nordisk A/S
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Orphan Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Novo Nordisk A/S Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 AstraZeneca
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Orphan Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 AstraZeneca Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Eisai Co., Ltd.
9.12 Daiichi Sankyo Company Limited
9.13 Bayer AG
9.14 GlaxoSmithKline
9.15 Merck & Co., Inc.
9.16 Johnson & Johnson
9.17 Biogen, Inc.
9.18 Shire
9.19 Amgen, Inc.

10 ORPHAN DRUGS MAUFACTURING COST ANALYSIS

10.1 Orphan Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Orphan Drugs
10.3 Manufacturing Process Analysis of Orphan Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Orphan Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Orphan Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ORPHAN DRUGS MARKET FORECAST (2017-2022)

14.1 Global Orphan Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Orphan Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Orphan Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Orphan Drugs Price and Trend Forecast (2017-2022)
14.2 Global Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Orphan Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Orphan Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Orphan Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Orphan Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Orphan Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Orphan Drugs Price Forecast by Type (2017-2022)
14.4 Global Orphan Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Orphan Drugs
Figure Global Orphan Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Orphan Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oncology Product Picture
Figure Gastrointestinal Product Picture
Figure Pulmonary Product Picture
Figure Neurology Product Picture
Figure Hematology Product Picture
Figure Cardio-vascular Product Picture
Figure Metabolic disorders Product Picture
Figure Endocrinology Product Picture
Figure Infectious diseases Product Picture
Figure Others Product Picture
Figure Global Orphan Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Orphan Drugs by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Speciality Pharmacies Examples
Table Key Downstream Customer in Speciality Pharmacies
Figure Retail pharmacies Examples
Table Key Downstream Customer in Retail pharmacies
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Orphan Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Orphan Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Orphan Drugs Sales Volume (K Units) (2012-2017)
Table Global Orphan Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Orphan Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Orphan Drugs Sales Share by Players/Suppliers
Figure 2017 Orphan Drugs Sales Share by Players/Suppliers
Figure Global Orphan Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Orphan Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Orphan Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Orphan Drugs Revenue Share by Players
Table 2017 Global Orphan Drugs Revenue Share by Players
Table Global Orphan Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global Orphan Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Orphan Drugs by Type (2012-2017)
Figure Global Orphan Drugs Sales Growth Rate by Type (2012-2017)
Table Global Orphan Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Orphan Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Orphan Drugs by Type (2012-2017)
Figure Global Orphan Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Orphan Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Orphan Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Orphan Drugs by Region (2012-2017)
Figure Global Orphan Drugs Sales Growth Rate by Region in 2016
Table Global Orphan Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Orphan Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Orphan Drugs by Region (2012-2017)
Figure Global Orphan Drugs Revenue Growth Rate by Region in 2016
Table Global Orphan Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Orphan Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Orphan Drugs by Region (2012-2017)
Figure Global Orphan Drugs Revenue Market Share by Region in 2016
Table Global Orphan Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Orphan Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Orphan Drugs by Application (2012-2017)
Figure Global Orphan Drugs Sales Market Share by Application (2012-2017)
Figure United States Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States Orphan Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Orphan Drugs Sales Volume Market Share by Players in 2016
Table United States Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Orphan Drugs Sales Volume Market Share by Type in 2016
Table United States Orphan Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Orphan Drugs Sales Volume Market Share by Application in 2016
Figure China Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Orphan Drugs Sales Volume (K Units) by Players (2012-2017)
Table China Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Orphan Drugs Sales Volume Market Share by Players in 2016
Table China Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Orphan Drugs Sales Volume Market Share by Type in 2016
Table China Orphan Drugs Sales Volume (K Units) by Application (2012-2017)
Table China Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Orphan Drugs Sales Volume Market Share by Application in 2016
Figure Europe Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Orphan Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Orphan Drugs Sales Volume Market Share by Players in 2016
Table Europe Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Orphan Drugs Sales Volume Market Share by Type in 2016
Table Europe Orphan Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Orphan Drugs Sales Volume Market Share by Application in 2016
Figure Japan Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Orphan Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Orphan Drugs Sales Volume Market Share by Players in 2016
Table Japan Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Orphan Drugs Sales Volume Market Share by Type in 2016
Table Japan Orphan Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Orphan Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Orphan Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Volume Market Share by Application in 2016
Figure India Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Orphan Drugs Sales Volume (K Units) by Players (2012-2017)
Table India Orphan Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Orphan Drugs Sales Volume Market Share by Players in 2016
Table India Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Orphan Drugs Sales Volume Market Share by Type in 2016
Table India Orphan Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Orphan Drugs Sales Volume Market Share by Application in 2016
Table Novartis AG Basic Information List
Table Novartis AG Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Orphan Drugs Sales Growth Rate (2012-2017)
Figure Novartis AG Orphan Drugs Sales Global Market Share (2012-2017
Figure Novartis AG Orphan Drugs Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Orphan Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Orphan Drugs Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Company Orphan Drugs Revenue Global Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Corporation Orphan Drugs Sales Growth Rate (2012-2017)
Figure Celgene Corporation Orphan Drugs Sales Global Market Share (2012-2017
Figure Celgene Corporation Orphan Drugs Revenue Global Market Share (2012-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Orphan Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Orphan Drugs Sales Global Market Share (2012-2017
Figure F. Hoffmann-La Roche Ltd. Orphan Drugs Revenue Global Market Share (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Orphan Drugs Sales Growth Rate (2012-2017)
Figure Pfizer, Inc. Orphan Drugs Sales Global Market Share (2012-2017
Figure Pfizer, Inc. Orphan Drugs Revenue Global Market Share (2012-2017)
Table Sanofi S.A. Basic Information List
Table Sanofi S.A. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi S.A. Orphan Drugs Sales Growth Rate (2012-2017)
Figure Sanofi S.A. Orphan Drugs Sales Global Market Share (2012-2017
Figure Sanofi S.A. Orphan Drugs Revenue Global Market Share (2012-2017)
Table Alexion Pharmaceuticals, Inc. Basic Information List
Table Alexion Pharmaceuticals, Inc. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alexion Pharmaceuticals, Inc. Orphan Drugs Sales Growth Rate (2012-2017)
Figure Alexion Pharmaceuticals, Inc. Orphan Drugs Sales Global Market Share (2012-2017
Figure Alexion Pharmaceuticals, Inc. Orphan Drugs Revenue Global Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Orphan Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Orphan Drugs Sales Global Market Share (2012-2017
Figure Eli Lilly and Company Orphan Drugs Revenue Global Market Share (2012-2017)
Table Novo Nordisk A/S Basic Information List
Table Novo Nordisk A/S Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk A/S Orphan Drugs Sales Growth Rate (2012-2017)
Figure Novo Nordisk A/S Orphan Drugs Sales Global Market Share (2012-2017
Figure Novo Nordisk A/S Orphan Drugs Revenue Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Orphan Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Orphan Drugs Sales Global Market Share (2012-2017
Figure AstraZeneca Orphan Drugs Revenue Global Market Share (2012-2017)
Table Eisai Co., Ltd. Basic Information List
Table Daiichi Sankyo Company Limited Basic Information List
Table Bayer AG Basic Information List
Table GlaxoSmithKline Basic Information List
Table Merck & Co., Inc. Basic Information List
Table Johnson & Johnson Basic Information List
Table Biogen, Inc. Basic Information List
Table Shire Basic Information List
Table Amgen, Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Orphan Drugs
Figure Manufacturing Process Analysis of Orphan Drugs
Figure Orphan Drugs Industrial Chain Analysis
Table Raw Materials Sources of Orphan Drugs Major Players in 2016
Table Major Buyers of Orphan Drugs
Table Distributors/Traders List
Figure Global Orphan Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Orphan Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Orphan Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Orphan Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Orphan Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Orphan Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Orphan Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Orphan Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Orphan Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Orphan Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Orphan Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Orphan Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Orphan Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Orphan Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Orphan Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Orphan Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Orphan Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Orphan Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Orphan Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Orphan Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources